TIGR

TIGR is a protein historically associated with ocular physiology and inheritance patterns related to glaucoma. First characterized in linkage studies of familial ocular disease, TIGR became a focal point for researchers exploring protein folding disorders, extracellular matrix interactions, and intraocular pressure regulation. It has been studied across clinical genetics, protein biochemistry, and ophthalmic surgery cohorts.

History

Initial identification of the protein arose from pedigree analyses in families affected by juvenile-onset ocular hypertension and optic neuropathy, intersecting with research programs at institutions such as Mayo Clinic, Johns Hopkins University, and Massachusetts General Hospital. Early reports were presented in conferences hosted by societies including the Association for Research in Vision and Ophthalmology and published in journals affiliated with Nature Publishing Group, Elsevier, and Springer Nature. Subsequent locus mapping involved collaborations with consortia like the Human Genome Project teams and investigators linked to the National Institutes of Health. Functional follow-ups were performed in laboratories at Stanford University, Harvard Medical School, and University College London, integrating methods developed in groups led by investigators from Cold Spring Harbor Laboratory and European Molecular Biology Laboratory.

Biology and Function

The protein encoded at the corresponding locus is synthesized in tissues including the trabecular meshwork and ciliary body, and it partakes in extracellular interactions alongside components such as fibronectin, collagen, and laminin. Biochemical studies leveraging techniques from Max Planck Institute laboratories and methodologies described by researchers at Salk Institute have shown oligomerization tendencies and secretion pathways involving the endoplasmic reticulum and Golgi apparatus, paralleling pathways characterized in studies of heat shock protein 70 and calreticulin. Structural investigations employed crystallography and cryo-EM approaches using platforms associated with Argonne National Laboratory and Diamond Light Source, revealing domains related to olfactomedin-like folds, similar to domains examined in proteins studied at European Synchrotron Radiation Facility. Interactions with cell-surface receptors mirror themes found in research on integrin complexes and syndecan family members. Post-translational modifications characterized by groups at University of California, San Francisco include glycosylation and disulfide bond formation, comparable to patterns reported for proteins studied at Yale University and University of Cambridge.

Clinical Significance

Mutations identified in affected pedigrees have been cataloged by clinical genetics centers such as Mayo Clinic and diagnostic laboratories affiliated with Clinical Laboratory Improvement Amendments-accredited facilities. Specific missense and nonsense variants correlate with phenotypes reported in cohorts assembled at Bascom Palmer Eye Institute and Wills Eye Hospital, with genotype–phenotype analyses published in outlets linked to American Academy of Ophthalmology and British Journal of Ophthalmology. Therapeutic strategies evaluated in trials overseen by investigators at National Eye Institute and in surgical series from Moorfields Eye Hospital include interventions targeting intraocular pressure and trabeculectomy outcomes described in multicenter studies coordinated through networks like the European Glaucoma Society. Diagnostic pathways incorporate sequencing approaches validated by groups at Wellcome Sanger Institute and commercial panels from companies founded by alumni of MIT and Stanford University.

Research Applications

Model systems established to study the protein include transgenic and knockout animals generated at facilities such as The Jackson Laboratory, with phenotyping pipelines influenced by protocols from International Mouse Phenotyping Consortium and gene-editing performed using CRISPR platforms originating from work at Broad Institute and Zentrum für Molekulare Biologie der Universität Heidelberg. In vitro assays employ cell lines and primary cultures maintained according to standards used at National Center for Advancing Translational Sciences and biochemical screening methodologies adapted from European Molecular Biology Laboratory training. High-throughput compound screens leveraging technologies commercialized by firms spun out of Harvard University and University of California, Berkeley aim to identify small molecules modulating secretion or aggregation, with parallel proteostasis strategies inspired by research on amyloidogenic proteins at Alzheimer's Disease Research Center groups. Collaborative networks such as projects affiliated with Human Cell Atlas and imaging consortia using microscopes from Zeiss and Leica Microsystems provide resources for phenotypic characterization.

Nomenclature and Homology

The protein has been referred to by multiple historical names in the literature; standardized nomenclature and gene symbols were proposed following guidelines from organizations including the HUGO Gene Nomenclature Committee and adopted by databases curated at UniProt and NCBI. Homology searches conducted with tools developed at European Bioinformatics Institute and National Center for Biotechnology Information reveal conserved regions across vertebrate lineages, with orthologs reported in species cataloged by collections at Smithsonian Institution and Natural History Museum, London. Comparative studies reference sequence alignments and phylogenetic methods originating from groups at Carnegie Mellon University and Stanford University to place the protein within a family related to olfactomedin-domain proteins characterized in research from University of Tokyo and University of Sydney.

Category:Proteins